CompletedPhase 2NCT00403104

Placebo Controlled Study of ONO2506PO in the Presence of Riluzole in Patients With Amyotrophic Lateral Sclerosis (ALS)

Studying Amyotrophic lateral sclerosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Ono Pharmaceutical Co. Ltd
Principal Investigator
Tomohiro Kuwayama
Ono Pharmaceutical Co. Ltd
Intervention
ONO-2506PO(drug)
Enrollment
420 enrolled
Eligibility
18-74 years · All sexes
Timeline
20062008

Study locations (26)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00403104 on ClinicalTrials.gov

Other trials for Amyotrophic lateral sclerosis

Additional recruiting or active studies for the same condition.

See all trials for Amyotrophic lateral sclerosis

← Back to all trials